Clinical Assistant Professor, Gastroenterology, Baylor College of Medicine
Gastroenterology
Dr. Frank L. Lanza, MD
|
|
Give Review
Dr. Frank L. Lanza is an expert in the field of Gastroenterology. He studied medicine at Baylor College of Medicine. He received 1 awards: "Fellow (FACG)". Frank Lanza is a published doctor. He published 89 publications, including: 'A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Low-dose aspirin-induced Ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial.
- Effects of Aluminum/Magnesium Hydroxide and Calcium Carbonate on Esophageal and Gastric pH in Subjects with Heartburn.
- GastroIntestinal effects of low-dose aspirin.
- Bisphosphonates: oEsophageal and gastric toxicity--fact or fiction.
- In vitro assessment of bone marrow endothelial colonies (CFU-En) in non-Hodgkin''s lymphoma patients undergoing peripheral blood stem cell transplantation.
- Study of prognosis in acute myeloid leukemias (AML) by cluster analysis.
- Corrosive injury to the Stomach: the natural history and role of fiberoptic endoscopy.
- Gastroscopic evaluation of the effect of aspirin and oxaprozin on the Gastric mucosa.
- Effect of acetaminophen on human Gastric mucosal injury caused by ibuprofen.
- The endoscopic diagnosis of Gastric lymphoma. Gross characteristics and histology.
- Suppression of nocturnal acid secretion with famotidine accelerates gastric Ulcer healing.
- Calcium supplementation decreases rectal epithelial cell proliferation in subjects with sporadic adenoma.
- Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for...
- Clinical pharmacology of predisintegrated ibuprofen 800 mg tablets: an endoscopic and pharmacokinetic study.
- Bisphosphonate mucosal injury--the end of the story?
- A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.
- Endoscopy in the diagnosis of Gastric lymphoma and sarcoma.
- Esophageal dilatation: current instruments and technique.
- In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiUlcer agent.
- Endoscopic upper gastroIntestinal polypectomy. Report of 73 polypectomies in 63 patients.
- Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis--the influence of aspirin and cigarette smoking.
- Effect of ranitidine on gastroDuodenal mucosal damage induced by nonsteroidal antiinflammatory drugs.
- Evaluation of gastric Ulcerations.
- NSAIDs and the gastroIntestinal tract.
- Expression of platelet glycoprotein (GP) V in heterologous cells and evidence for its association with GP Ib alpha in forming a GP Ib-IX-V complex on the cell surface.
- The effects of flurbiprofen, aspirin, cimetidine, and antacids on the gastric and Duodenal mucosa of normal volunteers. An endoscopic and photographic study.
- Effects of flurbiprofen and aspirin on the gastric and Duodenal mucosa. An endoscopic comparison.
- Reduction in gastric mucosal hemorrhage and Ulceration with chronic high-level dosing of enteric-coated aspirin granules two and four times a day.
- Risk factors of anti-inflammatory drugs.
- Endoscopic studies of gastric and Duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents.
- An endoscopic evaluation of gastric Ulcer treated with a mixture containing bismuth ammonium citrate.
- Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and Duodenal mucosa.
- Efficacy of rabeprazole once daily for acid-related disorders.
- Effective maintenance treatment of reflux Esophagitis with low-dose lansoprazole. A randomized, double-blind, placebo-controlled trial.
- A review of mucosal protection by synthetic prostaglandin E analogs against injury by non-steroidal anti-inflammatory agents.
- The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the Gastric mucosa of normal volunteers: a gastroscopic and photographic study.
- Ethanol, aspirin, ibuprofen, and the gastroDuodenal mucosa: an endoscopic assessment.
- Effects of fenbufen, indomethacin, naproxen, and placebo on Gastric mucosa of normal volunteers. A comparative endoscopic and photographic evaluation.
- Prophylaxis against nonsteroidal anti-inflammatory drug-associated Ulcers and erosions: a commentary on the new data.
- A safe non-steroidal anti-inflammatory drug--the search continues.
- Etodolac compared with aspirin: an endoscopic study of the gastroIntestinal tracts of normal volunteers.
- Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis an...
- Effects of ibuprofen, tolmetin and placebo on the Gastric mucosa of aspirin-sensitive volunteers.
- Effect of enprostil on the gastroDuodenal mucosa of healthy volunteers.
- Is alendronate clinically gastrotoxic? Re: Graham et al. primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin.
- A review of gastric ulcer and gastroDuodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs.
- A controlled endoscopic study comparing the toxic effects of sulindac, naproxen, aspirin, and placebo on the Gastric mucosa of health volunteers.
- A double-blind study of prophylactic effect of misoprostol on lesions of gastric and Duodenal mucosa induced by oral administration of tolmetin in healthy subjects.
- A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and Duodenal mucosa.
- A guideline for the treatment and prevention of NSAID-induced Ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology.
- An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastroIntestinal mucosa.
- Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with Duodenal ulcer.
- Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastroIntestinal safety and analgesic efficacy in osteoarthritic patients.
- GastroIntestinal toxicity of newer NSAIDs.
- An endoscopic comparison of the gastroDuodenal injury seen with salsalate and naproxen.
- Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroDuodenal injury. Effect of scoring method.
- Role of antacids in the management of disorders of the upper gastroIntestinal tract. Review of clinical experience 1975-1985.
- The effect of bismuth subsalicylate on the histologic Gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
- A double-blind randomized placebo controlled gastroscopic study to compare the effects of indomethacin capsules and indomethacin suppositories on the Gastric mucosa of...
- Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
- Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroDuodenal damage than either aspirin or ibuprofen.
- Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the sto...
- An endoscopic comparison of gastroDuodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
- Effect of Helicobacter pylori infection on the severity of gastroDuodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers.
- Prevention of NSAID-related Ulcers.
- A multicenter, randomized, double-blind comparison of roxatidine with ranitidine in the treatment of patients with uncomplicated Benign gastric ulcer disease. The Mult...
- Seven-day therapy for Helicobacter pylori in the United States.
- Prevention of Duodenal ulcer recurrence with 15 mg lansoprazole: a double-blind placebo-controlled study. The Lansoprazole Study Group.
- A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer Disease. Multicenter Roxatidin...
- The American College of Gastroenterology Bleeding Registry: preliminary findings.
- NSAID-induced gastric Ulceration is dose related by weight: an endoscopic study with flurbiprofen.
- A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroDuodenal mucosal protection against damage from aspirin and effect on bowel h...
- A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and Duodenal ulceration.
- A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastri...
- Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute Duodenal ulcer. Lansoprazole Study Group.
- An endoscopic comparison of the effects of alendronate and risedronate on upper gastroIntestinal mucosae.
- Placebo-controlled, randomized, evaluator-blinded endoscopy study of risedronate vs. aspirin in healthy postmenopausal women.
- Effects of alendronate on gastric and Duodenal mucosa.
- Endoscopic comparison of esophageal and gastroDuodenal effects of risedronate and alendronate in postmenopausal women.
- The impact of low-dose aspirin on endoscopic gastric and Duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-s...
- A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and Duodenal ulcer rat...
- All-natural nitrite and nitrate containing dietary supplement promotes nitric oxide production and reduces triglycerides in humans.
- An assessment of the management of acute bleeding Varices: a multicenter prospective member-based study.
- The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study.
- A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosis.
- 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status.
- GastroIntestinal adverse effects of bisphosphonates: etiology, incidence and prevention.
- Guidelines for prevention of NSAID-related Ulcer complications.
Schools
University Of Texas Medical Branch At Galveston
Staten Island Usphs Hospital
Baylor Affil Hosps
University Tex MD Anderson Hospital
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Manometry
Conditions Treated
- Abdominal Pain
- Anemia
- Benign Neoplasm of the Digestive System
- Cholecystitis and Gallstones
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Houston Area HMO-Standard
- Medicare MCR
- MHealth Insured
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Principal Life
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Universal American
Awards
- Fellow (FACG)
Education
-
University of Texas MD Anderson Cancer Center -
Baylor College of Medicine -
University of Texas Medical Branch
Drug Facts
| NPI NUMBER | 1992705453 | |
| NPPES Provider LastName | LANZA | |
| NPPES Provider FirstName | FRANK | |
| NPPES Provider ZIPCode | 770741802 | |
| NPPES Provider State | TX | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 383.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 19.0 | |
| Percent Opioid Claims | 4.96 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1992705453 |
| Last Name Of The Provider | LANZA |
| First Name Of The Provider | FRANK |
| View All |
Similar Doctors
|
Dr. Nasrullah Manji, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Paul M. Mauk, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael W. Stavinoha, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Manreet Kaur, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ronald M. Rance, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Shailaja S. Behara, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bharat Pothuri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thuan T. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Bernard Levin, MB CHB |
|
|
Dr. John R. Stroehlein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hashim M. Khandwalla, MD
This Doctor is OpenDoctor Recommended.
|